News Tag: MAR
-
Ortivus appoints Gustaf Nordenhök as new CEO
We are happy to announce the recruitment of Gustaf Nordenhök as Ortivus’ new Chief Executive Officer and as a member of the management team. Gustaf assumes the position of CEO on January 1, and the outgoing CEO, Reidar Gårdebäck, will remain with the company until March 31, 2024.
-
Ortivus signs exclusive distributor agreement with digital health company HealthCare Software
Ortivus AB and HealthCare Software (HCS) have entered into a collaboration through an exclusive distributor agreement that encompasses the United Kingdom and Ireland. This strategic agreement provides Ortivus with the opportunity to offer HCS’ Controlled Drug Management solution. This solution ensures secure end-to-end management of controlled drugs in the prehospital care setting.
-
Ortivus receives MDR certificate
We are very proud to announce that Ortivus has been certified under the Medical Device Regulation (MDR) and that MobiMed continues to be a CE marked medical device. The certification means that our medical technology solutions are now compliant with the new European legislation for medical technology products, that was installed to guarantee patient safety.
-
Ortivus AB (publ) interim report for the period July – September 2023
A challenging quarter concludes on a positive note with restored delivery pace and several new contracts signed
